Mutations that reduce expression from the P2 promoter of the Escherichia coli galactose operon.

PubWeight™: 1.45‹?› | Rank: Top 5%

🔗 View Article (PMID 3516794)

Published in Gene on January 01, 1986

Authors

A H Bingham, S Ponnambalam, B Chan, S Busby

Articles citing this

Selectivity of the Escherichia coli RNA polymerase E sigma 38 for overlapping promoters and ability to support CRP activation. Nucleic Acids Res (1995) 1.98

Hierarchies of base pair preferences in the P22 ant promoter. J Bacteriol (1991) 1.89

Repression and activation of transcription by Gal and Lac repressors: involvement of alpha subunit of RNA polymerase. EMBO J (1995) 1.60

Interactions between the cyclic AMP receptor protein and the alpha subunit of RNA polymerase at the Escherichia coli galactose operon P1 promoter. Nucleic Acids Res (1994) 1.55

The organization of open complexes between Escherichia coli RNA polymerase and DNA fragments carrying promoters either with or without consensus -35 region sequences. Biochem J (1990) 1.43

A simple mechanism for co-dependence on two activators at an Escherichia coli promoter. EMBO J (2001) 1.43

Alterations in the binding site of the cyclic AMP receptor protein at the Escherichia coli galactose operon regulatory region. Biochem J (1988) 1.40

Location of close contacts between Escherichia coli RNA polymerase and guanine residues at promoters either with or without consensus -35 region sequences. Biochem J (1993) 1.27

Genetic flexibility of regulatory networks. Proc Natl Acad Sci U S A (2010) 1.20

Unusual properties of promoter-up mutations in the Escherichia coli galactose operon and evidence suggesting RNA polymerase-induced DNA bending. EMBO J (1987) 1.15

Repression and catabolite gene activation in the araBAD operon. J Bacteriol (1987) 1.14

Effect of mutations in the cyclic AMP receptor protein-binding site on araBAD and araC expression. J Bacteriol (1989) 1.11

Integrated analysis of transcriptomic and proteomic data. Curr Genomics (2013) 1.09

A second operator is involved in Pseudomonas aeruginosa elastase (lasB) activation. J Bacteriol (1999) 1.08

GalR mutants defective in repressosome formation. Genes Dev (1999) 1.06

Different thermal energy requirement for open complex formation by Escherichia coli RNA polymerase at two related promoters. Nucleic Acids Res (1991) 1.01

Asynchronous basepair openings in transcription initiation: CRP enhances the rate-limiting step. EMBO J (2004) 0.94

Correlation between the conformation of Escherichia coli -10 hexamer sequences and promoter strength: use of orthophenanthroline cuprous complex as a structural index. EMBO J (1988) 0.93

Cooperative action of the catabolite activator protein and AraC in vitro at the araFGH promoter. J Bacteriol (2000) 0.93

DNA sequences in gal operon override transcription elongation blocks. J Mol Biol (2008) 0.88

Positioning of region 4 of the Escherichia coli RNA polymerase sigma(70) subunit by a transcription activator. J Bacteriol (2000) 0.82

Induction of the galactose enzymes in Escherichia coli is independent of the C-1-hydroxyl optical configuration of the inducer D-galactose. J Bacteriol (2008) 0.80

Mutational analysis of the lac regulatory region: second-site changes that activate mutant promoters. Nucleic Acids Res (1989) 0.78

Differential role of base pairs on gal promoters strength. J Mol Biol (2014) 0.76

Articles by these authors

Cyclic AMP receptor protein: role in transcription activation. Science (1984) 8.37

Transcriptional regulation by cAMP and its receptor protein. Annu Rev Biochem (1993) 6.49

FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J (2000) 3.81

Stringent spacing requirements for transcription activation by CRP. Cell (1990) 3.52

Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database. Nucleic Acids Res (1999) 3.44

Mutations that alter the ability of the Escherichia coli cyclic AMP receptor protein to activate transcription. Nucleic Acids Res (1990) 3.08

Broad host range plasmids carrying the Escherichia coli lactose and galactose operons. FEMS Microbiol Lett (1992) 2.90

Activation and accumulation of B cells in TACI-deficient mice. Nat Immunol (2001) 2.85

Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency. Curr Biol (2001) 2.75

Mutations in the Escherichia coli operon that define two promoters and the binding site of the cyclic AMP receptor protein. J Mol Biol (1982) 2.30

On the action of the cyclic AMP-cyclic AMP receptor protein complex at the Escherichia coli lactose and galactose promoter regions. EMBO J (1984) 2.29

Identification of a contact site for different transcription activators in region 4 of the Escherichia coli RNA polymerase sigma70 subunit. J Mol Biol (1998) 2.19

A specific endonuclease from Bacillus caldolyticus. Nucleic Acids Res (1978) 2.18

Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet (1994) 2.12

Effect of population-based interventions on laboratory utilization: a time-series analysis. JAMA (1998) 2.09

Deletion mutagenesis of the Escherichia coli galactose operon promoter region. J Mol Biol (1983) 2.09

Mapping of transcription initiation and termination signals on Xenopus laevis ribosomal DNA. Proc Natl Acad Sci U S A (1982) 1.99

Isolation of mutant promoters in the Escherichia coli galactose operon using local mutagenesis on cloned DNA fragments. J Mol Biol (1982) 1.93

TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice. Nat Immunol (2001) 1.92

Recognition of nucleotide sequences at the Escherichia coli galactose operon P1 promoter by RNA polymerase. Gene (1989) 1.85

Segment-specific mutagenesis of the regulatory region in the Escherichia coli galactose operon: isolation of mutations reducing the initiation of transcription and translation. Gene (1983) 1.84

The role of two surface exposed loops in transcription activation by the Escherichia coli CRP and FNR proteins. Nucleic Acids Res (1991) 1.83

DNA sequence elements located immediately upstream of the -10 hexamer in Escherichia coli promoters: a systematic study. Nucleic Acids Res (2000) 1.79

The Escherichia coli RNA polymerase alpha subunit: structure and function. Curr Opin Genet Dev (1995) 1.77

Organisation of the regulatory region of the Escherichia coli melibiose operon. Gene (1987) 1.77

Treatment of the serotonin syndrome with cyproheptadine. J Emerg Med (1998) 1.76

Transcription initiation at the Escherichia coli galactose operon promoters in the absence of the normal -35 region sequences. J Biol Chem (1986) 1.76

The functional subunit of a dimeric transcription activator protein depends on promoter architecture. EMBO J (1994) 1.70

Nucleotide sequence, organisation and structural analysis of the products of genes in the nirB-cysG region of the Escherichia coli K-12 chromosome. Eur J Biochem (1990) 1.66

Comparison of the binding sites for the Escherichia coli cAMP receptor protein at the lactose and galactose promoters. EMBO J (1983) 1.65

Distinct compartmentalization of TGN46 and beta 1,4-galactosyltransferase in HeLa cells. Eur J Cell Biol (1997) 1.64

Electron microscopy of magnesium-depleted bacteria. J Bacteriol (1966) 1.60

Interactions between the Escherichia coli cyclic AMP receptor protein and RNA polymerase at class II promoters. Mol Microbiol (1993) 1.60

Interleukin 6 promotes murine lupus in NZB/NZW F1 mice. J Clin Invest (1994) 1.56

Appropriateness of primary total hip and knee replacements in regions of Ontario with high and low utilization rates. CMAJ (1996) 1.56

Interactions between the cyclic AMP receptor protein and the alpha subunit of RNA polymerase at the Escherichia coli galactose operon P1 promoter. Nucleic Acids Res (1994) 1.55

Cell surface glypicans are low-affinity endostatin receptors. Mol Cell (2001) 1.51

Transcription from the Escherichia coli melR promoter is dependent on the cyclic AMP receptor protein. Gene (1988) 1.48

Identification of the functional subunit of a dimeric transcription activator protein by use of oriented heterodimers. Cell (1993) 1.46

The organization of open complexes between Escherichia coli RNA polymerase and DNA fragments carrying promoters either with or without consensus -35 region sequences. Biochem J (1990) 1.43

A seven-gene operon essential for formate-dependent nitrite reduction to ammonia by enteric bacteria. Mol Microbiol (1994) 1.42

The purification of restriction endonuclease EcoRI by precipitation involving polyethyleneimine. FEBS Lett (1977) 1.42

The Escherichia coli melR gene encodes a DNA-binding protein with affinity for specific sequences located in the melibiose-operon regulatory region. Gene (1989) 1.40

Alterations in the binding site of the cyclic AMP receptor protein at the Escherichia coli galactose operon regulatory region. Biochem J (1988) 1.40

RNA polymerase makes important contacts upstream from base pair -49 at the Escherichia coli galactose operon P1 promoter. Gene (1987) 1.38

Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease. Arch Dis Child Fetal Neonatal Ed (1995) 1.37

Binding of the Escherichia coli cyclic AMP receptor protein to DNA fragments containing consensus nucleotide sequences. Biochem J (1989) 1.35

Location and orientation of an activating region in the Escherichia coli transcription factor, FNR. Mol Microbiol (1994) 1.35

Investigation of the Pseudomonas aeruginosa ampR gene and its role at the chromosomal ampC beta-lactamase promoter. FEMS Microbiol Lett (1993) 1.34

The financial performance of hospitals belonging to health networks and systems. Inquiry (2000) 1.34

The economic cost of musculoskeletal disorders in Canada. Arthritis Care Res (1998) 1.33

Functional analysis of different sequence elements in the Escherichia coli galactose operon P2 promoter. Mol Microbiol (1988) 1.32

Comparison of promoter activities in Escherichia coli and Pseudomonas aeruginosa: use of a new broad-host-range promoter-probe plasmid. FEMS Microbiol Lett (1990) 1.31

Cyclic AMP-dependent constitutive expression of gal operon: use of repressor titration to isolate operator mutations. Proc Natl Acad Sci U S A (1983) 1.30

Transcriptional co-activation at the ansB promoters: involvement of the activating regions of CRP and FNR when bound in tandem. Mol Microbiol (1995) 1.28

Location of close contacts between Escherichia coli RNA polymerase and guanine residues at promoters either with or without consensus -35 region sequences. Biochem J (1993) 1.27

Forward and retrograde trafficking in mitotic animal cells. ER-Golgi transport arrest restricts protein export from the ER into COPII-coated structures. J Cell Sci (1999) 1.26

TGN38 and its orthologues: roles in post-TGN vesicle formation and maintenance of TGN morphology. Biochim Biophys Acta (1997) 1.25

Pseudomonas stimulates interleukin-8 mRNA expression selectively in airway epithelium, in gland ducts, and in recruited neutrophils. Am J Respir Cell Mol Biol (1994) 1.21

Clathrin light chains: arrays of protein motifs that regulate coated-vesicle dynamics. Trends Biochem Sci (1991) 1.20

A Golgi localization signal identified in the Menkes recombinant protein. Hum Mol Genet (1998) 1.20

The Escherichia coli cysG promoter belongs to the 'extended -10' class of bacterial promoters. Biochem J (1993) 1.18

The selection and characterisation of two novel mutations in the overlapping promoters of the Escherichia coli galactose operon. Gene (1984) 1.18

Regulation and sequence of the structural gene for cytochrome c552 from Escherichia coli: not a hexahaem but a 50 kDa tetrahaem nitrite reductase. Mol Microbiol (1993) 1.17

Humanization of an anti-lymphocyte function-associated antigen (LFA)-1 monoclonal antibody and reengineering of the humanized antibody for binding to rhesus LFA-1. J Immunol (1996) 1.17

Overexpression, purification and characterization of the Escherichia coli MelR transcription activator protein. Biochem J (1992) 1.16

Macrophage/monocyte receptor for nonenzymatically glycosylated protein is upregulated by cachectin/tumor necrosis factor. J Clin Invest (1989) 1.15

Oral health sensations associated with illicit drug abuse. Br Dent J (2005) 1.11

Isolation and partial characterization of four plasmids from antibiotic-resistant thermophilic bacilli. J Gen Microbiol (1979) 1.11

Irradiation of choroidal melanoma with iodine 125 ophthalmic plaque. Arch Ophthalmol (1980) 1.11

Evidence for prebudding arrest of ER export in animal cell mitosis and its role in generating Golgi partitioning intermediates. Traffic (2001) 1.10

Optimizing recovery after laparoscopic colon surgery (ORAL-CS): effect of intravenous ketorolac on length of hospital stay. Surg Endosc (2007) 1.10

A novel whole blood capillary technic for measuring the prothrombin time. Am J Clin Pathol (1987) 1.09

Studies with the Escherichia coli galactose operon regulatory region carrying a point mutation that simultaneously inactivates the two overlapping promoters. Interactions with RNA polymerase and the cyclic AMP receptor protein. FEBS Lett (1987) 1.08

Anterior lung herniation: another aspect of the seatbelt syndrome. J Trauma (1995) 1.06

A distinct subset of chemokines dominates the mucosal chemokine response in inflammatory bowel disease. Aliment Pharmacol Ther (2005) 1.06

Unwinding of duplex DNA during transcription initiation at the Escherichia coli galactose operon overlapping promoters. FEBS Lett (1990) 1.06

Studies on the binding of the Escherichia coli MelR transcription activator protein to operator sequences at the MelAB promoter. Biochem J (1992) 1.06

Expression of active human factor IX in transfected cells. Nature (1985) 1.05

Public opinion on smoke-free policies in restaurants and predicted effect on patronage in Hong Kong. Tob Control (2002) 1.05

Transcription activation by Escherichia coli FNR protein: similarities to, and differences from, the CRP paradigm. Nucleic Acids Res (1998) 1.05

An evaluation of the potential to use tumor-associated antigens as targets for antitumor T cell therapy using transgenic mice expressing a retroviral tumor antigen in normal lymphoid tissues. J Exp Med (1993) 1.04

Identification of a di-leucine motif within the C terminus domain of the Menkes disease protein that mediates endocytosis from the plasma membrane. J Cell Sci (1999) 1.04

Radiation therapy of choroidal melanoma. Trans Ophthalmol Soc U K (1977) 1.04

On the binding of tRNA to Escherichia coli RNA polymerase. Interactions between the core enzyme, DNA and tRNA. Eur J Biochem (1981) 1.04

Activation and repression of transcription initiation in bacteria. Essays Biochem (2001) 1.03

Increased cell proliferation and associated expression of PDGFRbeta causing hypercellularity in patellar tendinosis. Rheumatology (Oxford) (2001) 1.02

Schizosaccharomyces pombe ypt5: a homologue of the rab5 endosome fusion regulator. Mol Biol Cell (1993) 1.01

Different thermal energy requirement for open complex formation by Escherichia coli RNA polymerase at two related promoters. Nucleic Acids Res (1991) 1.01

Characterization of Bacillus stearothermophilus plasmid pab124 and construction of deletion variants. J Gen Microbiol (1980) 1.00

Corticotropin-releasing factor inhibits antigen-induced plasma extravasation in airways. Eur J Pharmacol (1995) 1.00

Interactions between the Escherichia coli MelR transcription activator protein and operator sequences at the melAB promoter. Biochem J (1994) 1.00

A study of demographic changes under sustained below-replacement fertility in Hong Kong SAR. Soc Sci Med (2001) 0.99

Protein-protein interactions during transcription activation: the case of the Escherichia coli cyclic AMP receptor protein. Philos Trans R Soc Lond B Biol Sci (1996) 0.98